Pharmaceuticals (Apr 2021)

Luminescent Phage-Based Detection of <i>Klebsiella pneumoniae</i>: From Engineering to Diagnostics

  • Lior Zelcbuch,
  • Elad Yitzhaki,
  • Olga Nissan,
  • Eliya Gidron,
  • Nufar Buchshtab,
  • Edith Kario,
  • Sharon Kredo-Russo,
  • Naomi B. Zak,
  • Merav Bassan

DOI
https://doi.org/10.3390/ph14040347
Journal volume & issue
Vol. 14, no. 4
p. 347

Abstract

Read online

Bacteriophages (“phages”) infect and multiply within specific bacterial strains, causing lysis of their target. Due to the specific nature of these interactions, phages allow a high-precision approach for therapy which can also be exploited for the detection of phage-sensitive pathogens associated with chronic diseases due to gut microbiome imbalance. As rapid phage-mediated detection assays becoming standard-of-care diagnostic tools, they will advance the more widespread application of phage therapy in a precision approach. Using a conventional method and a new cloning approach to develop luminescent phages, we engineered two phages that specifically detect a disease-associated microbial strain. We performed phage sensitivity assays in liquid culture and in fecal matrices and tested the stability of spiked fecal samples stored under different conditions. Different reporter gene structures and genome insertion sites were required to successfully develop the two nluc-reporter phages. The reporter phages detected spiked bacteria in five fecal samples with high specificity. Fecal samples stored under different conditions for up to 30 days did not display major losses in reporter-phage-based detection. Luminescent phage-based diagnostics can provide a rapid co-diagnostic tool to guide the growing field of phage therapy, particularly for a precision-based approach to chronic diseases treatment.

Keywords